Kim, S. J.
Garcia-Recio, S.
Creighton, C. J. http://orcid.org/0000-0002-6090-703X
Perou, C. M. http://orcid.org/0000-0001-9827-2247
Rosen, J. M. http://orcid.org/0000-0002-6637-844X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RO1 CA 148761, RO1 CA148761, CA148761, RO1 CA148761, RO1 CA148761)
Susan G. Komen (PDF17479425)
Article History
Received: 19 March 2018
Revised: 20 March 2019
Accepted: 14 April 2019
First Online: 9 July 2019
Change Date: 26 September 2019
Change Type: Correction
Change Details: The original version of this Article incorrectly matched the supplementary files with their titles. This has been corrected. The following information has also been added to the Methods section.
Compliance with ethical standards
:
: CMP is an equity stock holder, consultant, and Board of Director Member, of BioClassifier LLC and GeneCentric Diagnostics. CMP is also listed an inventor on patent applications on the Breast PAM50 and Lung Cancer Subtyping assays. The other authors declare that they have no conflict of interest.